Podcasts about Medical cannabis

This week I'm joined by Dr. Simon Erridge, medical doctor, UCL researcher, and one of the UK's leading voices in medical cannabis. We delve into how Medical Cannabis really impacts our bodies and how people are actually accessing the drug?My book ‘Healthy Shouldn't Be This Hard': ⁠https://www.amazon.co.uk/Healthy-Shouldnt-Be-This-Hard-ebook/dp/B0G1DHNRV5⁠This episode is sponsored by:DIOME: Rest deeper. Stay grounded. Rested is available now and Grounded lands later this month. 

EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to announce that the company has entered into a Technology Evaluation and License Option Agreement with Swiss Cannabis Selection, a Switzerland-based medical cannabis company focused on the cultivation, development, and production of cannabis and cannabinoid-based products for medical applications. Charleton explained that SCS is collaborating with Schibano Pharma AG, a Swiss phytopharmaceutical company specializing in cannabinoid-derived active pharmaceutical ingredients, medicinal products, and wellness solutions, to evaluate EnWave's proprietary Radiant Energy Vacuum (REV™) dehydration technology. The evaluation is intended to determine the suitability of the technology across a range of cannabinoid and botanical products as both companies seek innovative solutions that can improve processing efficiency while maintaining product quality. Under the terms of the agreement, SCS and Schibano will conduct a comprehensive assessment of REV™ technology. Upon successful completion of the evaluation program, SCS will have the option to negotiate a commercial licensing agreement that would provide rights to deploy the technology within specified markets and applications. The agreement follows a series of recent commercial-scale evaluations of REV™ technology that delivered encouraging results. According to EnWave, the testing demonstrated that the technology can significantly accelerate drying processes while preserving important product characteristics that are critical for medical and pharmaceutical-grade cannabis products. Independent testing conducted across multiple cannabis cultivars showed no statistically significant differences in sensory quality when compared to conventionally dried products. The evaluations also found no meaningful impact on cannabinoid potency, no material changes in total yeast and mold counts, and generally stable terpene profiles, all of which are key quality metrics within the cannabis industry. One of the most notable findings from the testing was the potential reduction in drying times by approximately two to five days compared to traditional drying methods. Management believes this could create substantial operational benefits, including increased production throughput, improved facility utilization, and reduced dry-room occupancy, ultimately helping producers improve efficiency and lower operating costs. Charleton noted that maintaining product quality while increasing processing speed is becoming increasingly important as the global medical cannabis and cannabinoid-derived pharmaceutical markets continue to expand. The company believes REV™ technology offers a differentiated solution capable of addressing these industry challenges. #proactiveinvestors #enwavecorporation #tsxv #enw #REVTechnology #MedicalCannabis #CannabisTechnology #Pharmaceuticals #REVTechnology #Cannabinoids #Biotech #HealthInnovation #SwissCannabis #ProcessingTechnology

Chair of the National Trauma Committee of the Royal Australasian College of Surgeons Dr John Crozier has warned Clinton Maynard people will die if the NSW government allows people to drive with medicinal cannabis in their system.See omnystudio.com/listener for privacy information.

Two mothers fought British bureaucracy to obtain lifesaving cannabis medicines for their children. But most patients are having to go private – at huge cost Written and read by Kojo Koram. Help support our independent journalism at theguardian.com/longreadpod

Can full-spectrum cannabis work better than isolates — even if it tastes worse?In Part 2 with Seann Poli of JAN Rx, Trevor explores CBG, CBC, acidic cannabinoids, the entourage effect, veteran cannabis care, and why cannabis companies are increasingly filling healthcare roles traditionally held by pharmacists and nurses. Plus: a new “rocket fuel” cannabinoid blend, hormone-focused cannabis products, and the future of medical cannabis guidance in Canada.Listen now.Seann Poli - LinkedInJANrx -WebsiteTranscripts, papers and so much more at: reefermed.ca

Here are the stories we cover in this weeks show: Macky:  Warnings the medicinal cannabis industry could turn deadly without tougher regulation | ITV News Channel  Smee: Police defend decision to dismantle another Leicester cannabis grow | Leicestershire Live  Dr.Margaret: Marijuana Can Play A Role In Combating Obesity, Contrary To Stereotypes About Lazy Stoners With The Munchies, New Federally Funded Study Suggests Billy: UK Medical Cannabis Imports Hit 30 Tonnes as Canadian Producers Bypass European Processors  John: Federal Judge Dismisses Anti-Marijuana Groups' Lawsuit Challenging Medicare Hemp Coverage Program We have some propaganda as usual, where it is claimed medical cannabis can turn deadly if its not properly regulated! Ridiculous! Also, we see evidence that cannabis can help reduce obesity, regardless of the stereotypical Munches it gives us. Police in the UK defend their actions of taking down a cannabis grow, amongst backlash from social media messages. The UK has imported over 30 tonnes of cannabis form Canada! And some USA cannabis company is making it harder for new people to join the industry!  Lots going on in the world of cannabis news! I hope you enjoy the episode! 

  Purpose of the episode: Jeff Krajnak, a combat veteran, shares how medical cannabis helped him reduce opioid dependency and how THC metabolite laws led to criminal charges despite no impairment. Military service with the Navy Seabees and SEAL teams in Iraq and Afghanistan left Jeff with severe PTSD, fibromyalgia, and ankylosing spondylitis, resulting in a medical discharge in December 2013. Post-discharge, Jeff was consuming 11 opioid and psychiatric pills daily, drinking a bottle of vodka a day, and described himself as detached, suicidal, and hospitalized in a psych ward for eight days. Switching to medical cannabis — an indica strain for sleep and a CBD cream for pain — allowed Jeff to reduce from 11 pills to just one, and eventually quit opioids entirely. A 2017 car accident occurred when another driver ran a red light; Jeff and his son were uninjured, he cooperated with police, passed three field sobriety tests, and showed no signs of impairment. Despite every officer on scene testifying he was not impaired, Jeff was arrested 32 days later by a SWAT team due to THC metabolites in his blood — 4 nanograms active, 40 nanograms metabolite — exceeding Nevada's 2-nanogram legal limit. Charges included two felony B counts — felony DUI resulting in death and felony child neglect — carrying a potential 16–20 year prison sentence. Jeff accepted an Alford plea to felony reckless driving and misdemeanor DUI; the judge acknowledged he was not impaired but stated the law left her no choice. Probation terms banned cannabis use, forcing Jeff back onto 22 pills daily — highlighting the legal contradiction that allows high-dose opioid use while prohibiting medical cannabis. Nevada's 2-nanogram THC limit dates to 1999 and is based on a 1986–87 study measuring residual THC in reckless drivers' urine — not impairment — making it scientifically unsound. THC can remain in blood for weeks in chronic users, and up to 90 days depending on testing method and consumption type, meaning the legal limit bears no relationship to actual impairment. Other states apply higher or more flexible standards — California, Washington, and Colorado allow 5 nanograms with rebuttal options, and Michigan does not prosecute medical patients — contrasting sharply with Nevada's near-zero-tolerance approach. Jeff advocates for impairment-based DUI laws rather than residual THC thresholds, arguing that trained Drug Recognition Experts can assess actual impairment without relying on metabolite levels. As president of the Coalition for Patient Rights, Jeff is pushing for federal cannabis de-scheduling — arguing Schedule 3 is insufficient — and working with NORML, MPP, and other organizations to advance legislative reform. Visit our website: CannabisHealthRadio.comDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

  State lawmakers are headed back up to Utah's Capitol Hill this week for the first interim session since the legislative general session ended in March. Among the things being discussed tonight is medical cannabis here in Utah. You'll recall that the federal government changed the scheduling for state-issued medical marijuana last month, and now the state has to look at its own laws to see how things will change here.  

Can medical cannabis care become more personalized and patient-focused? Trevor and Kirk talk with Seann Poli of JANrx about raising capital during the early LP boom to building a 100% Canadian, independent medical cannabis company.Seann tells us about veteran cannabis care, challenges dealing with insurance companies, CBD/CBN products, medical cannabis education, and the future of holistic cannabinoid wellness in Canada.Learn how personalized cannabis support is helping veterans manage PTSD, sleep, pain, and overall health for veterans and civilians alike.Seann Poli - LinkedInJANrx -WebsiteTranscripts, papers and so much more at: reefermed.ca

It's Monday, May 18. Here are today's top stories around Central Indiana. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org and follow us on social media to get local news every day. WFYI News Now is hosted by Barb Anguiano and produced by Zach Bundy. Subscribe wherever you get your podcasts.

Boy howdy do we have something to talk about with our favorite medical cannabis subject matter expert today! On April 23, 2026, the U.S. Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) signed an order reclassifying (rescheduling) state-licensed medical marijuana and FDA-approved marijuana products from Schedule I to Schedule III of the Controlled Substances Act). Let's get into it with Dr. Mikhail “Misha” Kogan, chief medical officer of the GW Center for Integrative Medicine, associate professor of Medicine at the GW School of Medicine & Health Sciences, and author of the highly acclaimed book “Medical Marijuana: Dr. Kogan's Evidence-Based Guide to the Health Benefits of Cannabis and CBD.” Along with being an internationally recognized expert on medicinal cannabis, Dr. Kogan has extensive training and expertise in internal medicine, geriatrics, palliative care, social and primary care medicine, integrative medicine, herbal medicine, and craniosacral therapy. He specializes in diagnosing and developing treatment plans for the most complex health challenges, offering hope to even the most desperate patients. His specific area of interest is utilizing cannabis as a solution to reduce polypharmacy in the geriatric patient population. He is a renowned international speaker in the field of medical cannabis. ◘ Related Links The Society of Cannabis Clinicians https://bit.ly/48xFsrR Medical Marijuana: Dr. Kogan's Evidence-Based Guide to the Health Benefits of Cannabis and CBD https://bit.ly/4tMfWI1 GW Integrative Medicine Podcast: Medical Cannabis, Psilocybin, & More Playlist https://bit.ly/4n2A325 Science Friday interviews Dr. Kogan (25 min.) https://bit.ly/429HsTE Developing Medical Cannabis Competencies: A Consensus Statement https://bit.ly/4cN9wlK ◘ Transcript bit.ly/3JoA2mz ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

https://vimeo.com/1186533175?share=copy&fl=sv&fe=ci https://www.currentfederaltaxdevelopments.com/podcasts/2026/4/25/2026-04-27-no-more-280e-for-state-legal-medical-cannabis-businesses This week we look at: Tax Implications of the Rescheduling of State-Licensed Medical Marijuana Disallowance of COVID-19 Leave Credits: A Review of Substantiation and Trade or Business Requirements Substantiation, Entity Indebtedness, and Business Expense Deductibility: An Analysis of the Simmons Case The Tenth Circuit Codifies the Reach of the Economic Substance Doctrine Over Mechanical Statutory Compliance Treatment of Loyalty Rewards Program Funds and the Claim of Right Doctrine Valuation and Penalty Controversies in Estate Tax Examinations

The Trump Administration is changing federal cannabis policy. On Thursday acting Attorney General Todd Blanche signed an order reclassifying medical marijuana from a Schedule I to a Schedule III drug. That puts the drug in the same category as substances like ketamine and anabolic steroids. Now, this doesn’t mean cannabis is legal nationwide, and people with convictions related to marijuana won’t see their charges dropped. But officials say it’ll allow for more research into cannabis for medical use. For distributors in the 40 states that have medical marijuana systems already in place, it could mean tax benefits and less hoops to jump through when selling cannabis. This reclassification does not impact recreational marijuana. But advocates say it could be a sign of bigger changes to come. Guest: Dr. Susan Ferguson, Director of the Addictions, Drug & Alcohol Institute at the University of Washington Related links: Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls Federal Marijuana Rescheduling Will End Discrimination In Housing, Healthcare And Employment For Medical Cannabis Patients (Op-Ed) - Marijuana Moment SAM CONDEMNS IN THE STRONGEST POSSIBLE TERMS THE TRUMP ADMINISTRATION’S ILLEGAL DIRECTIVE ON MARIJUANA RESCHEDULING - Smart Approaches to Marijuana Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

DEA rescthedules state-legal medical marijuana, but recreational cannabis stays on Schedule III (and 280E issues continue for those businesses), Seventh Circuit finds claim of right can be used to exclude income from taxation and more.

This week we look at: Tax Implications of the Rescheduling of State-Licensed Medical Marijuana Disallowance of COVID-19 Leave Credits: A Review of Substantiation and Trade or Business Requirements The Tenth Circuit Codifies the Reach of the Economic Substance Doctrine Over Mechanical Statutory Compliance Substantiation, Entity Indebtedness, and Business Expense Deductibility: An Analysis of the Simmons Case Treatment of Loyalty Rewards Program Funds and the Claim of Right Doctrine Valuation and Penalty Controversies in Estate Tax Examinations

Dr. Hemant Kumar Bid is a top educator in the field of Biotechnology and Medical cannabis. He serves as Program Director for the Morehouse School of Medicine, using his extensive background in biotechnology research and cannabinoid research to educate graduate students and infuse the industry with science-backed legitimacy. Recently, Hemant has become deeply engaged with Artificial Intelligence and Machine Learning through his academic, clinical, and program development work.  During our conversation we discuss: How AI and machine learning are accelerating drug discovery, enabling personalized treatment, and analyzing complex genomic and clinical data. How the Morehouse School of Medicine is updating its biotechnology curriculum to integrate AI/ML  Why the accuracy of AI predictions depends entirely on data quality fed into the models, making standardization, diverse representation, and clean datasets critical for success How AI can help reduce trial-and-error prescribing in favor of personalized care for specific patient conditions, optimized dosing, and potential adverse effects and/or drug interactions. Major challenges that need to be overcome before AI and ML can truely transform medical cannabis treatment.  Thanks to This Episode’s Sponsor: Tikun Olam Tikun Olam is the world’s first licensed medical cannabis company. With over 20 years of clinical cannabis research, Tikun Olam has conducted 7 clinical trials and published over two dozen academic journal studies using its heirloom cultivars. Tikun Olam products are designed for specific needs: pain relief, better sleep, digestive comfort, and neurological balance — all standardized for consistent, predictable results. If you’re curious to learn more about their products or research, they even offer a free one-on-one consultation with a licensed nurse. Shop online or find a dispensary at tikunolam.com Additional Resources Register for CannMed 26 Meet the CannMed 26 Speakers Review the Podcast

"We are not going after the high. What we're going for is symptom relief. Based on our research, employers are going to be saving $5,000 per participant per year."Is it time for employers to start covering medical cannabis?My guest this week is Emily Fisher, Founder of LeafWell. As a stage 4 breast cancer patient, Emily experienced firsthand the therapeutic benefits of cannabis when traditional opioid painkillers failed her. However, she also experienced the frustration of navigating the dispensary system without any clinical guidance or oversight.She founded LeafWell to solve this problem by connecting patients with licensed healthcare providers via telehealth to receive personalized, clinically-guided cannabis care plans. Now, LeafWell has served over 500,000 patients and is bringing their platform directly to self-funded employers.In this episode, we tackle the stigma and misconceptions surrounding medical cannabis in the workplace. Emily explains how LeafWell differentiates between "presence and impairment," the strict guardrails they use for safety-sensitive jobs, and why clinically-guided cannabis therapy is helping patients reduce or eliminate highly addictive opioids and expensive pharmaceuticals.If you are an employer or a benefits consultant looking for an innovative, holistic approach to managing chronic pain and reducing pharmacy spend, this conversation will completely change how you view cannabis as an employee benefit.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit https://www.paretohealth.com/fully-insured-vs-self-funding-with-paretohealth-spencer-podcast/?utm_source=youtube&utm_medium=referral&utm_campaign=SelfFundedwSpencer to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Intro: Medical Cannabis as an Employee Benefit? (00:04:05) Emily's Story: Surviving Stage 4 Breast Cancer (00:08:25) Launching LeafWell: Increasing Access, Education, & Research (00:11:55) Dispensary "Bud Tenders" vs. Clinically Guided Care (00:15:24) Why Cannabis is a $29 Billion Healthcare Savings Opportunity (00:18:01) Reducing Prescription Drugs & Avoiding the ER (00:21:15) Addressing the Elephant in the Room: Impairment at Work (00:26:32) Differentiating Between Presence (Urine Tests) and Impairment (00:29:29) Form Factors: Tinctures, Capsules, and Avoiding Inhalables (00:35:47) How the Endocannabinoid System Works (00:42:00) The Future: Will the Government Reschedule Cannabis? (00:46:54) How Employers Can Roll Out a Medical Cannabis ProgramKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

"We are not going after the high. What we're going for is symptom relief. Based on our research, employers are going to be saving $5,000 per participant per year."Is it time for employers to start covering medical cannabis?My guest this week is Emily Fisher, Founder of LeafWell. As a stage 4 breast cancer patient, Emily experienced firsthand the therapeutic benefits of cannabis when traditional opioid painkillers failed her. However, she also experienced the frustration of navigating the dispensary system without any clinical guidance or oversight.She founded LeafWell to solve this problem by connecting patients with licensed healthcare providers via telehealth to receive personalized, clinically-guided cannabis care plans. Now, LeafWell has served over 500,000 patients and is bringing their platform directly to self-funded employers.In this episode, we tackle the stigma and misconceptions surrounding medical cannabis in the workplace. Emily explains how LeafWell differentiates between "presence and impairment," the strict guardrails they use for safety-sensitive jobs, and why clinically-guided cannabis therapy is helping patients reduce or eliminate highly addictive opioids and expensive pharmaceuticals.If you are an employer or a benefits consultant looking for an innovative, holistic approach to managing chronic pain and reducing pharmacy spend, this conversation will completely change how you view cannabis as an employee benefit.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit https://www.paretohealth.com/fully-insured-vs-self-funding-with-paretohealth-spencer-podcast/?utm_source=youtube&utm_medium=referral&utm_campaign=SelfFundedwSpencer to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Intro: Medical Cannabis as an Employee Benefit? (00:04:05) Emily's Story: Surviving Stage 4 Breast Cancer (00:08:25) Launching LeafWell: Increasing Access, Education, & Research (00:11:55) Dispensary "Bud Tenders" vs. Clinically Guided Care (00:15:24) Why Cannabis is a $29 Billion Healthcare Savings Opportunity (00:18:01) Reducing Prescription Drugs & Avoiding the ER (00:21:15) Addressing the Elephant in the Room: Impairment at Work (00:26:32) Differentiating Between Presence (Urine Tests) and Impairment (00:29:29) Form Factors: Tinctures, Capsules, and Avoiding Inhalables (00:35:47) How the Endocannabinoid System Works (00:42:00) The Future: Will the Government Reschedule Cannabis? (00:46:54) How Employers Can Roll Out a Medical Cannabis ProgramKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

Based on data from 2023-24, roughly 23% of New Yorkers aged 21 or older reported cannabis use in the past 12 months. Although men generally have a higher prevalence of use than women, recent studies show a narrowing gap as female consumption rises. Despite this trend, research is sorely lacking on the impact of cannabis use on pregnancy, birth outcomes and overall health. Many advisory panels and organizations advise against the use of cannabis during pregnancy, but there are numerous reasons pregnant people choose to use. On today's episode, we'll talk through the evidence and provide best practices for caring for pregnant persons who use cannabis.  Related Content:  New York State Department of Health Clinical Guidelines Program Therapeutic Use of Medical Cannabis in New York State (October 2025): https://www.suguidelinesnys.org/guideline/med-cannabis/?mytab=tab_6/#pregnancy New York State Department of Health Office of Cannabis Management Cannabis Considerations for Pregnant and Breastfeeding/Chest Feeding Individuals (2022): https://cannabis.ny.gov/system/files/documents/2022/07/cannabis-considerations-for-pregnant-and-breastfeeding-chestfeeding-individuals-fact-sheet_v2.pdf New York State Behavioral Risk Factor Surveillance System Brief (November 2024-05): https://www.health.ny.gov/statistics/brfss/reports/docs/2024-05_brfss_cannabis_use.pdf New York State Office of Cannabis Management Cannabis Education Library: https://cannabis.ny.gov/education Zolotov Y, Mendoza Temple L, Isralowitz R, et al. Developing Medical Cannabis Competencies: A Consensus Statement. JAMA Netw Open. 2025;8(10):e2535049. doi:10.1001/jamanetworkopen.2025.35049 Raz M, Gupta-Kagan J, & Asnes A. THC Ingestions and Child Protective Services: Guidelines for Practitioners. J Addict Med. 2025 July-Aug;19(4):350-52. doi:10/1097/ADM.0000000000001441 Data to Action: Cannabis consumption during the perinatal period and clinicians' screening and advising, New York State outside of New York City, 2017-2018 and 2021-2022: https://apps.health.ny.gov/public/tabvis/PHIG_Public/prams/publications/Cannabis_consumption_during_the_perinatal_period.pdf Project CBD: http://projectcbd.com/ American College of Gynecologists and Obstetrics Clinical Consensus on Cannabis Use during Pregnancy and Lactation (October 2025): https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2025/10/cannabis-use-during-pregnancy-and-lactation CEI Training, Clinical Approaches to Medical Cannabis: https://ceitraining.org/courses/1589 CEI Clinical Consultation Line 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health. https://ceitraining.org/  

Join our hosts for Thursday's show where we will be discussing: 'Medical cannabis: doing more harm than good?' and 'Fighting Frailty'. Medical cannabis: doing more harm than good? Recent studies have shown that cannabis use for medicinal purposes may be doing more harm than good. Join us as we look further into cannabis and the slippery slope of drug use in society. Fighting Frailty Have you ever thought about how ageing affects your strength, independence, and overall wellbeing? What exactly is frailty, and can it be prevented or even reversed? Join us as we explore practical steps we can take to stay strong and healthy for longer. Guests: Kevin Dinneen Peter Reynolds -  Expert in the Science, Medicine, Law and Politics of Drugs Dr David Tang - Consultant in Emergency Medicine Dr Osama Hamid Amtul Jameel Dr Hasham Imam Qamar Zafar Producers: Farhana Khan, Kafi Zafar and Amtul Shakoor

In this episode of The Ganjapreneur Podcast, host TG Branfalt speaks with Dr. Gil Fanciullo, a longtime physician specializing in pain management and palliative care, about his early experiences recommending cannabis to patients well before it was legally accepted. Drawing from decades in medicine, including his work at Dartmouth-Hitchcock Medical Center, Fanciullo reflects on the risks physicians once faced, the patient-driven origins of medical cannabis adoption, and how attitudes within the medical community have evolved over time. This interview explores the gaps that still exist in cannabis research, the complexities of cannabinoids and the so-called “entourage effect,” and the role cannabis could play in reducing reliance on pharmaceuticals like opioids. Fanciullo also discusses physician education, regulatory barriers, and what federal rescheduling could mean for both medical practice and the broader cannabis industry.

What's your grow question?The weirdest “secondhand high” isn't smoke drifting across a room, it's the aftershock of telling someone you love that cannabis is part of your life. When a friend, parent, partner, or co-parent finds out you use cannabis or make edibles at home, the hardest part often isn't dosing or infusion, it's finding words that don't trigger fear, shame, or a fight.I walk through why these conversations can feel so loaded: cultural residue from prohibition, the one-sided “experience gap,” and the added pressure when cannabis is still illegal where someone lives. Rather than defaulting to “it's legal” or sounding like you're building a courtroom defense, I focus on bridge-building language that starts with the relationship. You'll hear a simple framework for picking the right moment, getting clear on what you want (validation, permission, transparency), and deciding what's up for negotiation.Find the Cannabis Conversations Card on the episode page. If you're trying to live without compartmentalizing, this is a grounded guide for having the talk and then following through afterward. What's the toughest reaction you've gotten when you brought up cannabis?Join the Grower's Ask Me Anything on Thursday, April 2nd, 8pm EST. Now being streamed on YouTube! Send questions in advance to stayhigh@bitemepodcast.com!Support the show Visit the website for full show notes, free dosing calculator, recipes and more. 

Send us Fan MailThe most convincing health claims are the ones that feel personal, and few topics are as personal as medical cannabis for mental health. We take on a huge Lancet meta-analysis that pulled together 54 trials and thousands of participants to ask a simple question: does medical cannabis actually help anxiety, depression, and PTSD more than placebo? The answer is uncomfortable, especially given how common “medical marijuana for mental health” has become, and we walk through what the evidence says, where the risks may be, and why this can lead to hard but necessary conversations between patients and doctors. Then we shift to pet science based on listener requests and break down diabetes in dogs in plain language. We cover what canine diabetes mellitus is, what causes it, which dog breeds may be higher risk, and the classic symptoms owners report like increased thirst, frequent urination, increased appetite, and weight loss. We also flag diabetic ketoacidosis as an emergency, explain how diagnosis works through blood and urine testing, and outline what treatment often looks like with insulin, diet, exercise, and routine vet checkups. If you learn something, subscribe, share the episode with a friend, and leave a review so more science and pet lovers can find the show.Our LinksAll our social links are here!Support the showFor Science, Empathy, and Cuteness!Being Kind is a Superpower.All our social links are here!

Where are you listening from?A kid goes from hospice care to riding bikes again, and suddenly the cannabis conversation stops being theoretical. We sit down with Sasha, Executive Director of Realm of Caring, to unpack how that kind of outcome sparked a nonprofit that now helps tens of thousands of people navigate cannabinoid therapy with less fear and more facts.We talk about what “taking the confusion out of cannabis” actually looks like when you're a patient, a parent, or a caregiver. Sasha explains the biggest misconceptions she still runs into, why cannabis stigma stays so loud, and how Realm of Caring creates a safe place for basic questions and high-stakes decisions. You'll hear how their free one-on-one support works, what to look for in safer products (yes, certificates of analysis), and why tracking small changes like sleep, anxiety, or daily function can be more useful than chasing instant “miracle” results.We also dig into cannabis research and why scientific validation matters, including Realm of Caring's partnership with Johns Hopkins University and the value of long-term real-world data on commercially available products. One of the most powerful takeaways: improved outcomes can reduce caregiver burden, strengthening the whole family, not just the person using CBD, THC, CBG, or other cannabinoids. We close with concrete ways to help, from joining research (including options for non-users as controls) to donating monthly and sharing resources. Visit RealmofCaring.org and Podcasthon.orgSubscribe for more conversations like this, share the episode with someone who needs a trustworthy cannabis education resource, and leave a review so more listeners can find it.Join the FREE Grow Your Knowledge Challenge in the Bite Me Cannabis Club and join the Grower's Ask Me Anythingon Thursday, April 2nd, 8pm EST. LINK HERE. Find the Fresh Start Complete 30 Tolerance Break Guide on Amazon in paperback or Kindle and do a t-break when you're ready! Science shows even a short break can be helpful!Support the show Visit the website for full show notes, free dosing calculator, recipes and more. 

In this episode of Curry Café, hosts Ray Gary and Rick McNamara talk with guest Tony Stoddard about the medicinal uses of cannabis. They explore the science of the endocannabinoid system, methods for creating medical-grade cannabis products, the differences between Indica and Sativa strains, and personal stories of healing, including Tony's sister's cancer journey. The show also addresses cannabis legality, safe use, and the importance of balanced THC/CBD ratios for optimal health benefits. We encourage anyone with differing views to participate in future Curry Café discussions. If you would like to join the panel, email contact@kciw.org or call 541-661-4098. Hosts: Ray Gary, Rick McNamer; Producers: Ray Gary, Rick McNamer Intro and end music by Kat Liddell. Used with permission. The opinions expressed here are those of the individual participants. Curry Coast Community Radio takes no position on issues discussed in this program. The information provided is not intended to substitute for professional medical advice. Always seek the advice of your personal physician or other qualified healthcare professional before changing your healthcare treatment, diet, or lifestyle. If you enjoy this program and want to hear more like it, consider supporting Curry Coast Community Radio. Here’s How.

In this episode of MiCannaCast, we sit down with Jake Greba— founder of Midnight Roots, longtime legacy cultivator, edible pioneer, and music producer Bass Owl — for a deep, wide-ranging conversation about cannabis culture, genetics, medicine, creativity, and the journey from underground roots to the modern legal market.Jake shares powerful personal stories about growing up in a cannabis family, using the plant to help loved ones through serious medical conditions, navigating the pre-legal era, and building a respected brand rooted in authenticity rather than hype.We also dive into strain selection philosophy, terpene appreciation, why THC percentage doesn't equal quality, the dilution of genetics in today's market, and how cannabis connects to memory, ritual, and community.Beyond cannabis, the conversation explores Jake's parallel life in music — touring, producing bass music, and the creative mindset that links art and cultivation.If you care about legacy cannabis culture, real genetics, meaningful consumption, or the intersection of creativity and plant medicine, this episode delivers one of the deepest conversations we've had on the show.

This week on the The Armor Men's Health Show, Donna Lee welcomes Stephen Macenas, a Physician Associate with Urology Specialists of Austin, to answer an important listener question:“Are there holistic options for treating erectile dysfunction?”Stephen walks us through how providers take a whole-body approach when evaluating ED. That includes looking at blood flow, lifestyle habits, supplements, smoking status, sleep quality, nutrition, and overall cardiovascular health. He explains how these factors play a key role in the holistic urology care provided by the team.One supplement often recommended to support healthy blood flow is Arterosil, a cardiovascular supplement that many of the practice's providers consider a strong starting point when exploring supplement-based ED support. Stephen also discusses several other supplement options that may help improve circulation and vascular health.Later in the episode, Stephen shares details about his newest passion project: Green Dreams Health, a medical cannabis practice based in Austin. Through Green Dreams Health, patients can receive an evaluation and, if appropriate, a prescription for medical cannabis that is dispensed through Texas Original, the state's licensed provider.Stephen also talks about recent updates from Greg Abbott, which have expanded access to medical cannabis for Texans who may benefit from it.You might be surprised to hear a urology practice discuss medical cannabis, but Stephen explains why many patients may qualify — including those living with chronic pain, cancer, and other qualifying conditions.Learn more about Green Dreams Health at https://greendreamshealth.com, where you can schedule a free telemedicine consultation with Stephen.For more information about the show and men's health resources, visit https://armormenshealth.com. You can also submit a question there for the team to answer anonymously on a future episode.If you enjoyed this episode, please share the podcast with a friend and help spread the word about men's health!

Lawmakers are considering the bill as part of a broader conversation about treatment options for patients with serious illness.

Greg's wide-ranging commentary during Monday's highlighting several key developments shaping Alabama politics this week. He begins with the recent election of Rep. Scott Stadthagen as the new leader of the Alabama Republican Party. Greg discusses what the leadership change could mean for the party moving forward and the priorities that may emerge under Stadthagen's leadership.Turning to the Alabama Legislature, Greg highlights several issues lawmakers are expected to tackle at the Statehouse in the coming days. From budget discussions to policy proposals, he outlines what listeners should be watching as the legislative session continues to unfold.Greg also brings listeners up to date on the latest developments surrounding Alabama's Medical Cannabis program with licensing delays and ongoing legal challenges involving the Alabama Medical Cannabis Commission, Greg explains where the program currently stands and what it could mean very soon for communities across the state.It's a fast-paced commentary covering the stories and decisions that are shaping Alabama right now.

Send a textOn the latest episode of The Cannabis Conversation, our host, Anuj Desai, speaks with Thomas Gray & Nikita Cretu, the co-founders of Lumino, Europe's leading recruitment agency for the legal cannabis industry.We explore the history of the podcast, delve a little bit into Anuj's story, and share the big news on the podcast's future going forward.❇️ Get in touch at https://www.thecannabisconversation.euConnect with Thomas Gray on LinkedIn:  /thomas-c-s-gray Connect with Nikita Cretu on LinkedIn:  /nikita-cretu-b24b83a8 ---You can also listen in via:

Welcome to Episode 295 of Autism Parenting Secrets.This week, we shine a light on one of the most misunderstood and often controversial therapies in the autism world: medical cannabis.My guest is Dr. David Berger, known to many simply as Dr. David.He's a board-certified pediatrician with over 25 years of clinical experience.He's the founder of Wholistic Pediatrics & Family Care in Tampa, Florida, where he helps children and adults address root causes behind challenges like autism, ADHD, and immune dysfunction.He's also the founder of Wholistic ReLeaf, Florida's first pediatric medical cannabis clinic, where he's guided countless families in using cannabis-based therapies safely, responsibly, and with clear medical oversight.Dr. David brings both compassion and clarity to this conversation, helping parents understand how cannabis can support calm, focus, and balance when used appropriately as part of a broader, integrative approach.We dive into the science, the misconceptions, and the real-world application of using cannabis as medicine, along with what every parent should understand before considering this option.The secret this week is… Cannabis Is Medicine - If You Know How To Use ItYou'll Discover:How A Personal Family Experience With CBD Sparked Dr. Berger's Clinical Use Of Cannabis (2:12)What Every Parent Should Understand About The Endocannabinoid System And Why It Matters (9:00)How Different Cannabinoids (CBD, CBG, CBN, THC) Serve Very Different Therapeutic Purposes (11:42)The Research Showing Endocannabinoid Deficiency In Children With Autism (14:39)Why Many Children Respond Quickly And How To Introduce Cannabis Safely And Responsibly (18:58)About Our Guest:Dr. David Berger is a board-certified pediatrician with over 25 years of clinical experience and a national reputation for his integrative approach to family and pediatric care.  He is the founder of Wholistic Pediatrics & Family Care and Wholistic ReLeaf, Florida's first pediatric medical cannabis clinic. His practice specializes in autism, ADHD, allergies, immune dysfunction, and chronic complex conditions, combining nutritional, lifestyle, and biomedical therapies to address root causes.  A leading voice in the responsible use of medical cannabis for children, Dr. Berger is one of only a few pediatricians in Florida qualified to certify patients under the age of 18. He has also advised the FDA on vaccine safety and launched DrDavidMD, a media and education platform focused on health, education, and medical choice.wholisticfamilycare.comdrdavidmd.comReferences In This Episode:Dr. David's YouTube ChannelP2I HealthAdditional Resources:To learn more about personalized 1:1 support go to www.elevatehowyounavigate.comTake The Quiz: What's YOUR Top Autism Parenting Blindspot?If you enjoyed this episode, share it with your friends.

Joe Salome, co-founder of The Georgia Hemp Company and Simple Leaf Wellness, and former CMO of Halcyon Organics, is a respected figure in medical cannabis policy, instrumental in the passage of Georgia's landmark Haleigh's Hope Act (2014) and the 2019 Georgia's Hope Act.The discussion centers on Salome's personal advocacy, which was ignited after witnessing the therapeutic benefits of cannabis in treating his mother's ovarian cancer, fueling his mission to champion natural alternatives. His legislative work was pivotal in incrementally legalizing low-THC oil access and establishing in-state production and distribution in Georgia.Key topics addressed include the ongoing struggles with federal regulatory clarity regarding hemp, the threat posed by potential bans on hemp extract products to small businesses and the legal market, and the critical need for federal reclassification of cannabis. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

There's more to cannabis than people realise. In this episode of Everything Is Personal, Angie Roullier shares her journey living with Charcot-Marie-Tooth disease (CMT), a hereditary neurological nerve disorder that causes progressive nerve damage, muscle weakness, and related symptoms, navigating a broken healthcare system, and discovering how the endocannabinoid system and plant medicine transformed her quality of life. From pharmaceutical dependency and kidney complications to education, advocacy, and whole-plant medicine — this conversation dives deep into: • Medical cannabis education • The endocannabinoid system explained • Autoimmune triggers & inflammation • Why THC and CBD work differently • Healthcare system failures • Cannabis stigma & rescheduling debate • Medical vs recreational cannabis If you want to understand how cannabis as medicine actually works — beyond the headlines — this episode is essential. EndoDNA: Where Genetic Science Meets Actionable Patient Care EndoDNA bridges the gap between complex genomics and patient wellness. Our patented DNA analysis platforms and AI technology provide genetic insights that support and enhance your clinical expertise. Click here to check out to take control over your Personal Health & Wellness   Connect with EndoDNA on SOCIAL: IG | X | YOUTUBE | FB Connect with host, Len May, on IG     Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

This Healing System Was Hidden From You | Endocannabinoid System Explained In this episode of Everything Is Personal, we expose why cannabis and the endocannabinoid system are missing from modern medicine. This conversation explains the endocannabinoid system and how cannabis as medicine is changing the future of natural healing and holistic health. Our guest shares how he became one of the first medical students in the US to bring medical cannabis education into a medical school, how stigma and outdated policies block progress, and why patients are already using this plant to heal when medicine fails. This episode will challenge what you think you know about healthcare, pharmaceuticals, and alternative medicine, and reveal why true healing requires education, not suppression. EndoDNA: Where Genetic Science Meets Actionable Patient Care EndoDNA bridges the gap between complex genomics and patient wellness. Our patented DNA analysis platforms and AI technology provide genetic insights that support and enhance your clinical expertise. Click here to check out to take control over your Personal Health & Wellness   Connect with EndoDNA on SOCIAL: IG | X | YOUTUBE | FB Connect with host, Len May, on IG     Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Kenneth P. Finn is a distinguished physician specializing in Physical Medicine and Rehabilitation (PM&R) and Pain Medicine. With a medical career spanning over three decades, Dr. Finn has significantly contributed to pain management, medical education, and public health policy, particularly concerning cannabis use and its implications.Dr. Finn joins Dan to discuss the truth about medical cannabis and their effect on the human mind, body, and nervous system. He is also the editor of Cannabis in Medicine: An Evidence-Based Approach.Dr. Kenneth P. Finn, MD: A Leader in Pain Medicine and Cannabis ResearchCannabis in Medicine: An Evidence-Based Approach

What does medical cannabis look like when a King gets involved?Morocco, a country historically known for exporting outstanding Hashish, must import medicinal cannabis from aboard because its local crop doesn't meet the quality standards of Europe.The King of Morocco wants to bring Moroccan cannabis up to Good Agricultural and Collection Practices (GACP) so it can be used locally and be exported.Trevor and Kirk speak with Moroccan cannabis insider Dr. Redouane Rabii about Morocco's push into medical cannabis. From GACP standards and farmer training to cancer pain management and international exports, we explore how medicine, policy, and culture collide in one of the world's most famous cannabis regions.Dr. Rabii, a professor, an MD PhD, and a practicing Uro-Andrologist shares frontline clinical experience using cannabis for pain and cancer care—and why Morocco's medical system should follow Israel to succeed. Dr. Rabii has traveled the world and lends the King his expertise to help farmers, pharmaceutical companies, and laboratories fulfill the King's medical cannabis ambitions.Listen now to explore the future of medical cannabis in Morocco.Transcripts, papers and so much more at: reefermed.ca

I'll be joined by Ashley Surin's mom, Maureen, for an important conversation about their ongoing fight to access a medical cannabis product they describe as lifesaving for Ashley. We'll talk about Ashley's story, the barriers families face when seeking critical care options, and what this case says about the broader state of medical cannabis policy. You can sign the petition to support Ashley at ColeMemo.com/Ashley. Watch video version and read full show notes here: https://thecolememo.com/2026/01/16/e252/

New developments at the federal level have raised more questions than they've answered when it comes to cannabis and its use for treating various medical conditions. We talk with a reporter covering the cannabis industry as well as two medical researchers about what we do and don't know about the future of cannabis for medical use.

Dr. Jim Adams, Chief Medical Officer of Northwestern Medicine, joins Lisa Dent to discuss several health topics. Dr. Adams addresses the medication used in the newly-passed ‘medical aid in dying’ bill. He shares the latest information about medical cannabis, and how 2025 has been a year of unraveling progress in health.

 James McConkie represents the first guest from Northern Ireland on the podcast, discussing how cannabis laws differ between Northern Ireland (part of the UK) and the Republic of Ireland.Medical cannabis is legal in the UK only by prescription, requiring patients to have one diagnosed condition and try two treatments before qualifying for medical cannabis access.James began selling drugs including cannabis and cocaine after his father's death at age 13, followed by his mother's cancer diagnosis six months later, leading him into illegal activities throughout his teens.Police intervention at age 20-21 served as a wake-up call for James, prompting him to completely change his life direction and stop selling drugs while facing potential prison time.Isolation and self-reflection became key strategies for James to distance himself from criminal associates and rebuild his life through meetings and personal development.ADHD and autism diagnoses came at age 25, explaining lifelong challenges James experienced with concentration, food textures and colors, and social interactions that he hadn't understood previously.Cannabis provides significant relief for James's ADHD symptoms including impulsiveness, inability to concentrate, and autism-related issues with appetite and sleep disorders.Medication reduction from five prescriptions to two occurred after James began using medical cannabis through private clinics in the UK.UK law requires medical cannabis patients to use only dry herb vaporizers rather than smoking, despite allowing cigarette smoking which is known to be harmful.James's mother was diagnosed with schizophrenia, and he has served as her primary caregiver since age 23, adding complexity to his personal challenges.Night terrors and sleep disturbances from traumatic experiences during his drug-dealing years have been significantly improved through cannabis use before bedtime.Private medical cannabis treatment costs up to 750 pounds per month in the UK, with premium flower costing 160 pounds for 10 grams.James now works as a cannabis advocate, collaborating with Life clinic in Northern Ireland to help others understand medical cannabis options and transition away from traditional medications. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Bonni Goldstein is the Medical Director of Canna-Centers Wellness & Education, a leading cannabis medicine specialty practice, and the CEO of GoldsteinWellness.com, an educational platform dedicated to helping licensed healthcare professionals incorporate medical cannabis into their practices. Bonni has evaluated thousands of patients for medical cannabis treatment, with a special focus on treating children with intractable epilepsy, autism, and cancer. She authored the book Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain, and serves on the board of the International Alliance for Cannabinoid Medicine and Autism Safe Haven. Bonni has also been the medical director for the CannMed Medical Practicum since 2022. During our conversation, we discussed: Exciting updates to the CannMed Medical Practicum, including new topics (sports and recovery, cannabinoids and pregnacy, Pharmacokinetics and Product Formulation, and more) Findings from a California medical cannabis study showing diverse patients, high efficacy, and research gaps The importance of medical guidance when using cannabinoid therapies for complex conditions Safety issues with synthetic or semi-synthetic cannabinoids, and the importance of natural compounds and dosing education Goldstein Wellness as a resource for clinicians and patients, providing education, patient-clinician connections, and vetted product access Thanks to This Episode’s Sponsor: The Society of Cannabis Clinicians The Society of Cannabis Clinicians is a nonprofit professional association of physicians and other healthcare providers. It provides continuing education—for clinicians, patients, and all concerned about the medical use of cannabis and best practices in clinical care. SCC physicians have been monitoring cannabis use by patients for 20 years and have compiled a wealth of clinical evidence and treatment strategies that will be validated by clinical trials in the years ahead. To learn more about SCC and to join visit cannabisclinicians.org. Additional Resources GoldsteinWellness.com CannMed Medical Practicum

This week's news episode is a busy one, covering big shifts in the UK, Canada, and the US, and some pretty heated developments around hemp policy. Macky brings us a heartfelt BBC story about a patient who uses medical cannabis daily but fears being judged as a “lazy stoner.” A familiar issue… and one the UK still desperately needs to move past. Billy dives into Curaleaf's new partnership with ANTG, a deal that could reshape medical product manufacturing and distribution across the UK. Big players keep moving in, but will it actually help patients? Margaret Covers a Canadian piece asking why, after years of legalization, the public still wants cannabis modernization, and why they feel the government isn't delivering. John rounds things out with major U.S. news: Trump has officially signed a bill that recriminalizes hemp-derived THC products. On top of that, Congress effectively pulled the plug on the hemp market. A massive move that's already sparking controversy. Plenty to unpack, plenty to rant about, and definitely one of those weeks where the headlines tell very different stories depending on which side of the border you're standing on.

In this week's episode of High on Home Grown, we dive into the biggest cannabis headlines from around the world: Macky shares the inspiring story of a 72-year-old man who says medical cannabis gave him his life back. A powerful reminder of how this plant can change lives. (Liverpool Echo) Billy covers a new report showing that the UK medical cannabis industry could unlock over £5 billion per year, creating jobs and transforming healthcare access. (leafie) Margaret explores a fascinating study showing that cannabis beverages can reduce alcohol use and improve sleep, stress, and mood, hinting at a major lifestyle shift in the making. (Marijuana Moment) John reports on political progress across the pond. Virginia's new governor supports recreational cannabis legalization, while a Maryland task force recommends a phased plan to legalize psychedelics, starting with psilocybin. (Marijuana Moment) It's another packed episode of global cannabis and psychedelics news, full of positive steps forward and big changes on the horizon.

In episode 60 of Going anti-Viral, Dr Donald Abrams joins host Dr Michael Saag to discuss medical cannabis. Dr Abrams is a professor emeritus at the University of California San Francisco and a specialist in integrative oncology at the Osher Center for Integrative Health. Dr Abrams has studied complementary and alternative therapies, including mind-body treatments, botanical therapies, medical use of cannabis and herbal therapies used in traditional Chinese medicine. He continues to research the health effects of medical cannabis. Dr Abrams was previously at the forefront in HIV/AIDS research and treatment at San Francisco General Hospital and served as chief of the medical oncology service from 2003 to 2017. Dr Saag and Dr Abrams discuss the history of medical cannabis and the challenges Dr Abrams experienced in researching its use for medical therapy. They discuss the medical benefits of cannabis and the recommendations that clinicians may make as well as addressing the differences in products available including THC and CBD. They also discuss research in whether use of cannabis in young adults is related to schizophrenia. Finally, Dr Saag and Dr Abrams discuss the future of medical cannabis and whether physicians should continue to provide a role in its use, whether the scheduling of cannabis as a controlled substance will change, and the type of research that is needed to continue to explore where its use is beneficial. 0:00 – Introduction1:20 – Overview of the history of medical cannabis 4:10 – The fight for medical cannabis research and its use in people with AIDS 10:59 – Understanding the medical benefits of cannabis particularly for pain, insomnia, nausea, vomiting, anxiety, and depression 13:15 – How physicians navigate recommendations for the use of cannabis and the differences with the types of cannabis whether inhaled, digested, or tinctures 18:13 – CBD vs. THC: understanding the differences and other possible cannabinoid therapeutics23:25 – The role of physicians in the future of medical cannabis, the need for more research, and the overall availability for people who want it 25:57 – Overview of research if there a relationship between the use of cannabis and schizophrenia in young adults __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

This week on High on Home Grown, we're joined by our good friend Chad Westport for a packed episode of cannabis news from around the world! Here's what we're talking about: Macky covers how the UK cannabis supply could be disrupted after a major find in a former casino. Could this affect medical and underground markets? Spoiler alert... no!  Billy reports on ‘Significant Variation in Standards' across UK medical cannabis pharmacies, and what the latest ACMD review could mean for patients and prescribers. Margaret highlights Alternaleaf's new women's health cannabis service, the first of its kind in the UK, a big step for gender-focused cannabis care. John explores a fascinating new scientific glossary of marijuana aromas, developed to help consumers and producers better understand the world of terpenes. Including smells like, Baby Sick, Dog S**t, and Armpit....

Dr. Hemant Kumar Bid is a top educator in the field of Biotechnology and Medical Cannabis, where he uses his extensive background in biotechnology research and cannabinoid research to educate cannabis and biotechnology professionals and infuse the industry with science-backed legitimacy. In addition to serving as a Program Director for the Morehouse School of Medicine and teaching graduate students, Hemant also serves as a Scientific Advisor for Essentia Scientific, a company that delivers an array of cannabinoid product solutions, including acidic cannabinoids, with their patented water-as-solvent extraction technology. During our conversation, we discuss:  What are cannabinoid acids and how do they differ from the neutral cannabinoids  Why have cannabinoid acids been traditionally overlooked in research and consumer products  How THCA produces different effects than THC  Why CBDA is more bioavailable and more potent than CBD  How new extraction and stabilization techniques are helping make cannabinoids acids more accessible  and more  Thanks to This Episode's Sponsor: CANN Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org. Additional Resources Essentia Scientific Website Email Hemant - Hibid@msm.edu Submit Your Abstract for CannMed 26 Meet the CannMed 26 Advisory Board

In this week's episode of High on Home Grown, we've got a packed lineup of cannabis news from around the world. Here's what we're covering: Macky: “Dialing down dope”  Trump White House moves toward easing restrictions on marijuana. A big shift could be coming for cannabis in the U.S. as the Trump administration signals a softer stance on marijuana. We break down what this means for legalization and the industry moving forward. “Your Cannabis Habits May Be Written in Your DNA,” Scientists Say. A new study explores how genetics might influence how people use cannabis, from consumption habits to personal tolerance levels. Margaret: “Cannabis drinks are having a moment even as Americans consume less alcohol.” – CBS News. A deep dive into how cannabis-infused beverages are carving out a space in the drinks market, attracting both new consumers and seasoned users looking for an alternative to alcohol. Billy: “Cancer Patients to Benefit From Affordable Cannabis Medicine Program Launching in Colorado.” A groundbreaking new program aims to make medical cannabis more accessible and affordable for cancer patients in need. “Patients Aim to ‘Build Bridges' as European Medical Cannabis Series Comes to London.” Patients, advocates, and industry voices gather to push for better access to medical cannabis across Europe. Join us for the latest cannabis headlines, real discussions, and plenty of laughs along the way.